Hims & Hers Health, Inc.

NYSE:HIMS Rapporto sulle azioni

Cap. di mercato: US$3.6b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Hims & Hers Health Salute del bilancio

Salute finanziaria criteri di controllo 6/6

Hims & Hers Health ha un patrimonio netto totale di $362.0M e un debito totale di $0.0, che porta il suo rapporto debito/patrimonio netto a 0%. Le sue attività totali e le sue passività totali sono rispettivamente $480.5M e $118.5M. L'EBIT di Hims & Hers Health è $15.1M rendendo il suo rapporto di copertura degli interessi -1.5. Ha liquidità e investimenti a breve termine pari a $227.3M.

Informazioni chiave

0%

Rapporto debito/patrimonio netto

US$0

Debito

Indice di copertura degli interessi-1.5x
ContantiUS$227.29m
Patrimonio nettoUS$361.97m
Totale passivitàUS$118.53m
Totale attivitàUS$480.50m

Aggiornamenti recenti sulla salute finanziaria

Nessun aggiornamento

Recent updates

Hims & Hers: Digesting Q2 2024 Earnings, Shares Still Undervalued, Rating Downgrade

Aug 20

Hims & Hers Health, Inc.'s (NYSE:HIMS) Share Price Is Still Matching Investor Opinion Despite 27% Slump

Aug 11
Hims & Hers Health, Inc.'s (NYSE:HIMS) Share Price Is Still Matching Investor Opinion Despite 27% Slump

Hims & Hers Health: Buy The Dip, With Or Without The GLP-1 Shortage

Aug 07

Hims & Hers: The Thesis Goes Far Beyond GLP-1

Jul 18

Hims & Hers: Buy The Dip To Catch The Next Rip

Jun 24

Why Investors Shouldn't Be Surprised By Hims & Hers Health, Inc.'s (NYSE:HIMS) 70% Share Price Surge

Jun 19
Why Investors Shouldn't Be Surprised By Hims & Hers Health, Inc.'s (NYSE:HIMS) 70% Share Price Surge

Hims & Hers: The Undervalued Gem Poised For Growth

Jun 18

Beyond The Marketing Machine: Why Hims & Hers Stock Might Be Vulnerable

Jun 10

Hims & Hers Health, Inc.'s (NYSE:HIMS) CEO Compensation Is Looking A Bit Stretched At The Moment

May 31
Hims & Hers Health, Inc.'s (NYSE:HIMS) CEO Compensation Is Looking A Bit Stretched At The Moment

Hims & Hers: Soaring On Access To Compounded GLP-1 Drugs, Further Volatility Ahead

May 21

Hims & Hers Health: An Unforced Error

May 06

Hims & Hers Health, Inc. (NYSE:HIMS) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing

May 04
Hims & Hers Health, Inc. (NYSE:HIMS) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing

Hims & Hers Health: Becoming A Market Leader Within The Growing Digital Health Industry

Apr 24

Hims & Hers Health: Strong Prospects But Weak Business Model Consolidation

Apr 05

Hims & Hers: 5 Reasons Why This Is A Phenomenal Long-Term Growth Stock

Mar 21

Pills Pay The Bills: Mini Deep Dive On Hims & Hers Health

Mar 12

Investors Appear Satisfied With Hims & Hers Health, Inc.'s (NYSE:HIMS) Prospects As Shares Rocket 49%

Feb 28
Investors Appear Satisfied With Hims & Hers Health, Inc.'s (NYSE:HIMS) Prospects As Shares Rocket 49%

Hims & Hers: Turning The Profitability Corner And Returning 28%

Feb 25

Hims & Hers Health: No Clear Moat Besides First Mover Advantage

Jan 23

Hims & Hers Health: Unleashing Macro Momentum - Investing In Growth At A Higher Multiple

Jan 10

Investors Still Waiting For A Pull Back In Hims & Hers Health, Inc. (NYSE:HIMS)

Jan 07
Investors Still Waiting For A Pull Back In Hims & Hers Health, Inc. (NYSE:HIMS)

Hims & Hers Health Q3: The Cheapest Growth Stock Around

Dec 14

Hims & Hers Health: What Would The Author Of 100 Baggers Say?

Nov 30

Hims & Hers: The Most Undervalued Small Cap Stock I See

Nov 08

Hims & Hers: A Promising Company With Resolvable Challenges

Nov 02

Hims & Hers: Specialization Is The Secret To Great Growth

Oct 25

Hims & Hers Health: Can't Get Much Better

Sep 25

The Market Is Wrong On Hims & Hers Health

Sep 18

Hims & Hers: The Current Weakness Creates A Buying Opportunity

Aug 15

Hims & Hers Health: Giving Investors Another Bite At The Apple

Aug 01

Hims & Hers Health, Inc.'s (NYSE:HIMS) Price In Tune With Revenues

Jul 21
Hims & Hers Health, Inc.'s (NYSE:HIMS) Price In Tune With Revenues

Hims & Hers Health: Expect Strong EBITDA Growth As Revenue Growth Remains Strong

Jul 13

Hims & Hers Health: Double-Edged Sword

Jul 02

Hims & Hers: More Transparency Could Help The Stock

Jun 09

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( $290.9M ) di HIMS superano le sue passività a breve termine ( $108.7M ).

Passività a lungo termine: Le attività a breve termine di HIMS ( $290.9M ) superano le sue passività a lungo termine ( $9.9M ).


Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: HIMS è esente da debiti.

Riduzione del debito: HIMS non ha debiti rispetto a 5 anni fa, quando il suo rapporto debito/patrimonio netto era 14.3%.

Copertura del debito: HIMS non ha debiti, pertanto non deve essere coperto dal flusso di cassa operativo.

Copertura degli interessi: HIMS non ha debiti, pertanto la copertura dei pagamenti degli interessi non è un problema.


Bilancio


Scoprire le aziende sane